Stiffer Spleen Predicts Higher Bone Marrow Fibrosis and Higher JAK2 Allele Burden in Patients With Myeloproliferative Neoplasms

被引：5
|
作者：
Moia, Riccardo [1 ,2 ]
Cittone, Micol Giulia [2 ,3 ]
Boggione, Paola [1 ,2 ]
Manfredi, Giulia Francesca [2 ,3 ]
Favini, Chiara [1 ,2 ]
Awikeh, Bassel [1 ,2 ]
Pedrinelli, Anita Rebecca [2 ,3 ]
Mahmoud, Abdurraouf Mokhtar [1 ,2 ]
Nicolosi, Maura [1 ,2 ]
Bellan, Mattia [2 ,3 ]
Sainaghi, Pier Paolo [2 ,3 ]
Pirisi, Mario [2 ,3 ]
Gaidano, Gianluca [1 ,2 ]
Patriarca, Andrea [1 ,2 ]
Rigamonti, Cristina [2 ,3 ]
机构：
[1] Univ Piemonte Orientale, Dept Translat Med, Div Hematol, Novara, Italy
[2] Azienda Osped Univ Maggiore Carita, Novara, Italy
[3] Univ Piemonte Orientale, Dept Translat Med, Div Internal Med, Novara, Italy
来源：
FRONTIERS IN ONCOLOGY | 2021年 / 11卷
关键词：
myeloproliferative neoplasms; spleen stiffness; JAK2; mutations; vibration-controlled transient elastography (VCTE); NGS; TRANSIENT ELASTOGRAPHY; PORTAL-HYPERTENSION; STIFFNESS; LIVER;
D O I：
10.3389/fonc.2021.777730
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A total of 63 myeloproliferative neoplasms [MPN; 9 polycythemia vera (PV), 32 essential thrombocythemia (ET), and 22 myelofibrosis (MF)] underwent spleen stiffness (SS) measurement by vibration-controlled transient elastography equipped with a novel spleen-dedicated module. Higher SS values significantly correlated with grade 2-3 bone marrow (BM) fibrosis (p=0.035), with hemoglobin level <10 g/dl (p=0.014) and with white blood cells >= 10,000/mu l (p=0.008). Median SS was significantly higher in MF patients compared to ET and PV (p=0.015). SS also correlated with higher JAK2 variant allele frequency (p=0.02). This study identifies SS as a potential noninvasive tool that reflects BM fibrosis and the mutational burden in MPN.
引用
收藏
页数：5
相关论文
共 50 条
  • [41] TERT and JAK2 polymorphisms define genetic predisposition to myeloproliferative neoplasms in Japanese patients
    Masafumi Matsuguma
    Toshiaki Yujiri
    Kaoru Yamamoto
    Yasuko Kajimura
    Yoshihiro Tokunaga
    Mayumi Tanaka
    Yoshinori Tanaka
    Yukinori Nakamura
    Yukio Tanizawa
    International Journal of Hematology, 2019, 110 : 690 - 698
  • [42] Case series: patients with JAK2 positive myeloproliferative neoplasms associated with thrombotic events
    Combariza, J. F.
    Olaya, V
    Galvez, K.
    Ballesteros, L.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 88 - 88
  • [43] Overall Survival in Patients with JAK2 and ASXL1 Positive Myeloproliferative Neoplasms
    Al-Khabori, Murtadha
    Al-Zadjali, Shoaib
    Al Noumani, Iman
    Al Farsi, Khalil
    Al-Kindi, Salam
    Al Huneini, Mohamed
    Fawaz, Naglaa
    Sulayma, Al Lamki
    Al Bulushi, Mahdiya Pir
    Al Hashmi, Khalid
    Al Tarshi, Muna
    Almusalhi, Muhanna
    BLOOD, 2019, 134
  • [44] The G allele of the JAK2 rs10974944 SNP, part of JAK2 46/1 haplotype, is strongly associated with JAK2 V617F-positive myeloproliferative neoplasms
    Adrian P. Trifa
    Andrei Cucuianu
    Ljubomir Petrov
    Laura Urian
    Mariela S. Militaru
    Delia Dima
    Ioan V. Pop
    Radu A. Popp
    Annals of Hematology, 2010, 89 : 979 - 983
  • [45] The G allele of the JAK2 rs10974944 SNP, part of JAK2 46/1 haplotype, is strongly associated with JAK2 V617F-positive myeloproliferative neoplasms
    Trifa, Adrian P.
    Cucuianu, Andrei
    Petrov, Ljubomir
    Urian, Laura
    Militaru, Mariela S.
    Dima, Delia
    Pop, Ioan V.
    Popp, Radu A.
    ANNALS OF HEMATOLOGY, 2010, 89 (10) : 979 - 983
  • [46] JAK2 46/1 haplotype is associated with JAK2 V617F-positive myeloproliferative neoplasms in Japanese patients
    Tanaka, Mayumi
    Yujiri, Toshiaki
    Ito, Shunsuke
    Okayama, Naoko
    Takahashi, Toru
    Shinohara, Kenji
    Azuno, Yoichi
    Nawata, Ryouhei
    Hinoda, Yuji
    Tanizawa, Yukio
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 97 (03) : 409 - 413
  • [47] JAK2 46/1 haplotype is associated with JAK2 V617F-positive myeloproliferative neoplasms in Brazilian patients
    Macedo, L. C.
    Santos, B. C.
    Pagliarini-E-Silva, S.
    Pagnano, K. B. B.
    Rodrigues, C.
    Quintero, F. C.
    Ferreira, M. E.
    Baraldi, E. C.
    Ambrosio-Albuquerque, E. P.
    Sell, A. M.
    Visentainer, J. E. L.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2015, 37 (05) : 654 - 660
  • [48] JAK2 46/1 haplotype is associated with JAK2 V617F-positive myeloproliferative neoplasms in Japanese patients
    Mayumi Tanaka
    Toshiaki Yujiri
    Shunsuke Ito
    Naoko Okayama
    Toru Takahashi
    Kenji Shinohara
    Yoichi Azuno
    Ryouhei Nawata
    Yuji Hinoda
    Yukio Tanizawa
    International Journal of Hematology, 2013, 97 : 409 - 413
  • [49] Quantitative assessment of the JAK2 V617F allele burden: equivalent levels in peripheral blood and bone marrow
    T S Larsen
    N Pallisgaard
    M B Møller
    H C Hasselbalch
    Leukemia, 2008, 22 : 194 - 195
  • [50] IN JAK2V617F POSITIVE MYELOPROLIFERATIVE NEOPLASMS, BLEEDING RISK CORRELATES WITH ALLELE BURDEN
    Bertozzi, I.
    Cosi, E.
    Santarossa, C.
    Bogoni, G.
    Fabris, F.
    Randi, M. L.
    HAEMATOLOGICA, 2017, 102 : 811 - 811
12345